Share
Market Research Report

U.S. INJECTABLE COMPOUNDING PHARMACY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By MoleculeAcetaminophen · Phenylephrine · Midazolam · Esmolol · Vancomycin · Epinephrine · Adenocaine · Fentanyl/Bupivacaine · Morphine · Amiodarone · Fentanyl · Heparin · Ketamine · Dextrose · Hydromorphone · Bupivacaine · Lidocaine · BKK (Bupivacaine, Ketorolac, Ketamine) · RCK (Ropivacaine, Clonidine, Ketorolac) · RKK (Ropivacaine, Ketorolac, Ketamine) · Norepinephrine · Diltiazem · Vasopressin · Others
  • By Packaging TypeVials · Ampoules · Prefilled Syringes · Others
  • By Pharmacy Type503A Pharmacies · 503B Pharmacies
  • Published In25 Mar 2025
  • Report CodeCMI4478
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2025
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

U.S. Injectable Compounding Pharmacy

Market

Detailed Segmentation:

  • By Molecule (Revenue, USD Mn, 2021 - 2033)

    • Acetaminophen
    • Phenylephrine
    • Midazolam
    • Esmolol
    • Vancomycin
    • Epinephrine
    • Adenocaine
    • Fentanyl/Bupivacaine
    • Morphine
    • Amiodarone
    • Fentanyl
    • Heparin
    • Ketamine
    • Dextrose
    • Hydromorphone
    • Bupivacaine
    • Lidocaine
    • BKK (Bupivacaine, Ketorolac, Ketamine)
    • RCK (Ropivacaine, Clonidine, Ketorolac)
    • RKK (Ropivacaine, Ketorolac, Ketamine)
    • Norepinephrine
    • Diltiazem
    • Vasopressin
    • Others
  • By Packaging Type (Revenue, USD Mn, 2021 - 2033)

    • Vials
    • Ampoules
    • Prefilled Syringes
    • Others
  • By Pharmacy Type (Revenue, USD Mn, 2021 - 2033)

    • 503A Pharmacies
    • 503B Pharmacies